Skip to main content
Clinical Trials/NCT01201291
NCT01201291TerminatedNot Applicable

Impact of Inspired Oxygen Fraction on Outcome in Patients With Traumatic Brain Injury

Kuopio University Hospital8 sites in 1 country67 target enrollmentStarted: November 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
67
Locations
8
Primary Endpoint
Glasgow outcome scale(GOS) and/or Extended glasgow outcome scale (GOSE)

Study Overview

Brief Summary

Aim of the study is to investigate the impact of two different fractions of inspired oxygen (FiO2) on outcome in patients with severe traumatic brain injury (TBI).

Detailed Description

The high oxygen group is treated during mechanical ventilation with either a fraction of inspired oxygen of 0.7 (high oxygen group) or a fraction of inspired oxygen 0.4 (control group). The intervention continues until withdrawal of mechanical ventilation, ICU discharge or until 14 days from ICU randomisation.

Primary outcome is worse than expected outcome in the corresponding treatment arms based on outcome meas-ured by the probability of bad outcome using the CRASH® risk calculator (prognostic model for predicting outcome after traumatic brain injury).

Secondary outcome is occurence of lung injury during mechanical ventilation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with isolated non-penetrating traumatic brain injury
  • Multiple trauma patient with brain injury and traumas outside abdomen, thorax or pelvis not affecting oxygenation
  • Glasgow coma scale eight or less (inclusive)
  • Expected need for intubation and for mechanical ventilation more than 24 hours.
  • Are recruited <18 hours after admittance to ICU and
  • Time from TBI is less than 36 hours
  • Informed consent from patients representative

Exclusion Criteria

  • Age <18 or >65 years,
  • Anticipated brain death in 12 hours (donor treatment) or otherwise moribund patient expected to die in 24 hours
  • Expected need for mechanical ventilation less than 24 hours
  • Insufficient oxygenation assessed by a clinician or multiple trauma patients with brain injury and severe abdominal, thoracic or pelvic injury possibly affecting oxygenation.
  • No consent
  • Insufficient oxygenation with the treatment modality of the lower oxygenation group (Pa02 less than 13 kPa or SpO2 95% with Fi02 40%, PEEP 10 or less) or oxygenation failure probable during ICU care (severe aspiration, multiple trauma patients with brain injury and severe abdominal, thoracic or pelvic injury possibly affecting oxygenation)
  • Penetrating TBI
  • No consent
  • Suspected pregnancy (perform urinary or serological pregnancy test if suspected)

Arms & Interventions

Fraction of inspired oxygen of 0.4

Active Comparator

Fraction of inspired normobaric oxygen of 0.4 (low oxygen group)

Intervention: Normobaric oxygen (Other)

Fraction of inspired oxygen of 0.7

Active Comparator

Fraction of inspired normobaric oxygen of 0.7 (high oxygen group)

Intervention: Normobaric oxygen (Other)

Outcomes

Primary Outcomes

Glasgow outcome scale(GOS) and/or Extended glasgow outcome scale (GOSE)

Time Frame: 6 months

The study is powered to have 80% power at 5% significance level to detect a treatment effect that decreases the proportion of poor outcome from 55% to 45%. Each patient is given an individualized tailored prognosis based on patient's baseline prognosis in a large reference population. Outcome is measured by using functional outcome score, Glasgow outcome score (GOS) and/or GOS extended (GOSE).

Secondary Outcomes

  • 6 month outcome(6 months)

Investigators

Sponsor
Kuopio University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Stepani Bendel

MD

Kuopio University Hospital

Study Sites (8)

Loading locations...

Similar Trials

Impact of Inspired Oxygen Fraction on... | Clinical Trial